BioCentury
ARTICLE | Management Tracks

Stella to be CBO at Strand

Plus: CytoImmune hires Bogatyrenko and updates from Pureos, Centessa and Blackbird

March 2, 2023 2:05 AM UTC

Programmable mRNA therapeutics company Strand Therapeutics Inc. hired Jay Stella as CBO. Stella was SVP of corporate strategy at Akouos Inc. and worked in multiple roles at Takeda Pharmaceutical Co. Ltd. (Tokyo:4502; NYSE:TAK) for over 11 years.

CytoImmune Therapeutics Inc. also hired a CBO — Yulii Bogatyrenko, who joins the NK cell company from Biopharma C&I, a biotechnology consulting firm. Bogatyrenko is also a venture partner, consultant at ATEM Capital. Additionally, CytoImmune appointed Graeme Bell, CFO at Valo Health LLC, to its board. ...